First Dengue Vaccine Candidate to Show Efficacy Against Dengue Fever and Dengue Haemorrhagic Fever in Asia

88.5% reduction of Dengue Haemorrhagic Fever shown in detailed analyses of world’s first phase III efficacy study published in The Lancet – Two thirds reduction in hospitalization observed Favorable safety profile is consistent with safety documented in previous studies July 11, 2014 Sanofi Pasteur, the vaccines division of Sanofi, today announced the publication in The Lancet of the detailed results …

Small Bite, Big Threat: World Health Day

April the 7th was world health day! And the World Health Organization has decided to focus on vector-borne diseases and their prevention. Each year over a million people across the world are killed by vector-borne diseases such as malaria, dengue fever, and Japanese encephalitis, with millions more suffering because of them (Schistosomiasis alone affects nearly 240 million people worldwide.) Over …